Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 383

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

Open access
Zwaan, C. Michel, Kolb, Edward A., Reinhardt, Dirk, Abrahamsson, Jonas, Adachi, Souichi, Aplenc, Richard, De Bont, Eveline S.J.M., De Moerloose, Barbara, Dworzak, Michael, Gibson, Brenda E.S., Hasle, Henrik, Leverger, Guy, Locatelli, Franco, Ragu, Christine, Ribeiro, Raul C., Rizzari, Carmelo, Rubnitz, Jeffrey E., Smith, Owen P., Sung, Lillian, Tomizawa, Daisuke, van den Heuvel-Eibrink, Marry M., Creutzig, Ursula, Kaspers, Gertjan J.L.·2015·Journal of Clinical Oncology

Abstract

Diagnosis, treatment, response monitoring, and outcome of pediatric acute myeloid leukemia (AML) have made enormous progress during the past decades. Because AML is a rare type of childhood cancer, with an incidence of approximately seven occurrences per 1 million children annually, national and international collaborative efforts have evolved. This overview describes these efforts and includes a summary of the history and contributions of each of the main collaborative pediatric AML groups worldwide. The focus is on translational and clinical research, which includes past, current, and future clinical trials. Separate sections concern acute promyelocytic leukemia, myeloid leukemia of Down syndrome, and relapsed AML. A plethora of novel antileukemic agents that have emerged, including new classes of drugs, are summarized as well. Finally, an important aspect of the treatment of pediatric AML—supportive care—and late effects are discussed. The future is bright, with a wide range of emerging innovative therapies and with more and more international collaboration that ultimately aim to cure all children with AML, with fewer adverse effects and without late effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2015.62.8289

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 98 references

Cited by

See all 383

Metadata

Authors
Zwaan, C. M., Kolb, E. A., Reinhardt, D., Abrahamsson, J., Adachi, S., Aplenc, R., De Bont, E. S. J. M., De Moerloose, B., Dworzak, M., Gibson, B. E. S., Hasle, H., Leverger, G., Locatelli, F., Ragu, C., Ribeiro, R. C., Rizzari, C., Rubnitz, J. E., Smith, O. P., Sung, L., Tomizawa, D., van den Heuvel-Eibrink, M. M., Creutzig, U., & Kaspers, G. J. L.
Venue
Journal of Clinical Oncology
Published
2015-09-20
Volume
33
Issue
27
Pages
2949-2962
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2132693111
Cited by
383
References
98
FWCI
19.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. https://app.cochat.ai/papers/10.1200/jco.2015.62.8289
The paper
Zwaan, C. M., Kolb, E. A., Reinhardt, D., Abrahamsson, J., Adachi, S., Aplenc, R., De Bont, E. S. J. M., De Moerloose, B., Dworzak, M., Gibson, B. E. S., Hasle, H., Leverger, G., Locatelli, F., Ragu, C., Ribeiro, R. C., Rizzari, C., Rubnitz, J. E., Smith, O. P., Sung, L., . . . Kaspers, G. J. L. (2015). Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2015.62.8289

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.